We are pleased to announce that Manish Kumar has joined Intas Pharmaceuticals as Vice President. With extensive experience in biosimilar development, monoclonal and bispecific antibodies, and antibody-drug conjugates, Manish brings a strong scientific and strategic background to further strengthen Intas Pharmaceuticals’ research and development capabilities.
Before joining Intas Pharmaceuticals, Manish held leadership roles at Dr. Reddy’s Laboratories, where he headed ADCs, process, and analytical development. His expertise spans regulatory filings, functional characterization of biopharmaceuticals, and clinical bioanalytical methods. Having contributed significantly to various biosimilar programs, he has played a crucial role in advancing scientific strategies and regulatory processes on both global and domestic fronts.
With a PhD in Cell Biology, Molecular Biology, and Virology, along with years of experience leading multidisciplinary teams, Manish has been instrumental in driving innovation in biopharmaceutical research. His contributions at organizations like the University of Virginia Health System and Dr. Reddy’s Laboratories have helped shape the field of analytical sciences and biosimilarity assessments.
At Intas Pharmaceuticals, Manish will lead initiatives in biosimilar development, analytical sciences, and strategic R&D programs. His vast experience will be invaluable in advancing Intas Pharmaceuticals’ mission of delivering high-quality biopharmaceutical solutions to the global market.